Detalhe da pesquisa
1.
Validation of an automated, end-to-end metagenomic sequencing assay for agnostic detection of respiratory viruses.
J Infect Dis
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696336
2.
Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks.
BMC Infect Dis
; 24(1): 262, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408924
3.
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults.
BMC Infect Dis
; 24(1): 91, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225625
4.
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
Euro Surveill
; 29(7)2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362622
5.
The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults.
J Infect Dis
; 227(3): 339-343, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197948
6.
Two-phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID-19 serological assays as a proof of concept.
Vox Sang
; 118(12): 1069-1077, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850270
7.
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
Euro Surveill
; 28(5)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729117
8.
Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
J Infect Dis
; 225(8): 1387-1398, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215564
9.
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
J Infect Dis
; 226(1): 485-496, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084500
10.
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
Clin Infect Dis
; 74(7): 1158-1165, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244723
11.
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
Clin Infect Dis
; 75(1): e888-e891, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849655
12.
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Clin Infect Dis
; 75(11): 1980-1992, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438175
13.
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
Euro Surveill
; 27(38)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148674
14.
Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
Emerg Infect Dis
; 27(11): 2802-2809, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388358
15.
Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016).
BMC Public Health
; 21(1): 1388, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256707
16.
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017.
Clin Infect Dis
; 71(16): 2285-2288, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442261
17.
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
Euro Surveill
; 25(7)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098644
18.
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.
Clin Infect Dis
; 68(10): 1754-1757, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312364
19.
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic.
Euro Surveill
; 24(15)2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30994107
20.
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
Euro Surveill
; 24(46)2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31771709